BerandaMNKD • NASDAQ
add
MannKind Corp
$5,00
Setelah Jam Perdagangan Normal:(0,00%)0,00
$5,00
Tutup: 2 Mei, 16.02.22 GMT-4 · USD · NASDAQ · Pernyataan Penyangkalan
Tutup sebelumnya
$4,95
Rentang hari
$4,92 - $5,04
Rentang tahun
$4,17 - $7,63
Kapitalisasi pasar
1,52Â M USD
Volume Rata-Rata
1,97Â jt
Rasio P/E
51,45
Hasil dividen
-
Bursa utama
NASDAQ
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 76,78Â jt | 31,30% |
Biaya operasional | 35,11Â jt | 17,93% |
Laba bersih | 7,42Â jt | 429,76% |
Margin laba bersih | 9,67 | 302,92% |
Penghasilan per saham | — | — |
EBITDA | 24,22Â jt | 104,25% |
Tarif pajak efektif | 12,11% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 203,56Â jt | -32,60% |
Total aset | 393,84Â jt | -17,12% |
Total liabilitas | 472,66Â jt | -34,48% |
Total ekuitas | -78,82 jt | — |
Saham yang beredar | 303,59 jt | — |
Harga terhadap nilai buku | -19,04 | — |
Tingkat pengembalian aset | 12,86% | — |
Tingkat pengembalian modal | 52,03% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 7,42Â jt | 429,76% |
Kas dari operasi | 22,64Â jt | 4,46% |
Kas dari investasi | 48,22Â jt | 710,82% |
Kas dari pembiayaan | -86,90Â jt | -161,33% |
Perubahan kas bersih | -16,03Â jt | -110,31% |
Arus kas bebas | 30,14Â jt | 94,30% |
Tentang
MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991.
MannKind Corporation was named after its founder, Alfred E. Mann. Wikipedia
Didirikan
Feb 1991
Kantor pusat
Situs
Karyawan
405
